Showing 1,521 - 1,540 results of 8,597 for search 'effective dysfunction', query time: 0.14s Refine Results
  1. 1521

    Gene expression profiling of human umbilical vein endothelial cells overexpressing CELF2 as diagnostic targets in diabetes-induced erectile dysfunction by Daniyaer Nuerdebieke, Lizhong Yao, Lange Guo, Jiuzhi Li, Hongliang Jia, Yukui Nan

    Published 2025-07-01
    “…BackgroundErectile dysfunction (ED) is a common complication of diabetes mellitus (DM), and because of its complex neurovascular etiology, the associated molecular pathogenic mechanisms are not fully understood. …”
    Get full text
    Article
  2. 1522

    A Comprehensive Objective Evaluation Method for Handwriting Assistive Devices Using a Tablet and Digital Pen for Individuals with Upper Limb Dysfunction by Qian Li, Rui Gong, Kazunori Hase

    Published 2024-11-01
    “…However, statistical analysis revealed a significant mean difference between the two scoring methods, indicating that the objective method provides a more standardized and quantifiable evaluation, effectively minimizing the influence of personal biases inherent in subjective evaluations. …”
    Get full text
    Article
  3. 1523

    Remimazolam Combined with Andrographolide Improve Postoperative Cognitive Dysfunction in Rats after Cardiopulmonary Bypass through the AMPK/SIRT1 Signaling Pathway by Chong Chen, Lixia Lan, Kai Xu

    Published 2025-01-01
    “…Introduction: The effects of remimazolam (Re) in combination with andrographolide (AP) on learning, memory, and motor abilities in rats following cardiopulmonary bypass (CPB) surgery were studied. …”
    Get full text
    Article
  4. 1524

    Does metabolic dysfunction-associated fatty liver disease increase the risk of chronic kidney disease? A meta-analysis of cohort studies by Wanghao Liu, Xiaoying Sun

    Published 2024-12-01
    “…Abstract Objective Metabolic dysfunction-associated fatty liver disease (MAFLD) has been used to characterize patients with fatty liver and metabolic dysfunction. …”
    Get full text
    Article
  5. 1525

    Dietary Iron Supplementation Protects Against Growth Restriction and Metabolic Dysfunction‐Associated Steatotic Liver Disease in Perinatal Cadmium‐Exposed Mice by Rebecca Lichtler, Hannah Klossner, Nikia Smith, Cathrine Hoyo, Michael Cowley

    Published 2025-08-01
    “…Another comorbidity of ID and IDA is metabolic dysfunction‐associated steatotic liver disease (MASLD), a liver condition characterized by lipid accumulation and fibrosis. …”
    Get full text
    Article
  6. 1526

    Potential utility of the triglyceride-glucose index as a predictor of erectile dysfunction and its severity: a cross-sectional, case–control study by Huseyin Aytac Ates, Taha Burak Bulut

    Published 2025-07-01
    “…Abstract The aim of this case–control study was to evaluate the relationship between triglyceride-glucose index (TyG Index) and erectile dysfunction (ED) and its severity. A total of 230 male patients, aged between 18 and 75 years, admitted to the urology outpatient clinic with complaining erectile dysfunction were evaluated. …”
    Get full text
    Article
  7. 1527

    BMSC-Derived Exosomes Alleviate Sepsis-Associated Acute Respiratory Distress Syndrome by Activating the Nrf2 Pathway to Reverse Mitochondrial Dysfunction by Zhenzhen Li, Beijie Zheng, Chenchen Liu, Xiang Zhao, Yupeng Zhao, Xiangrui Wang, Lei Hou, Zhongwei Yang

    Published 2023-01-01
    “…However, the aforementioned BMSC-exo reversal of mitochondrial dysfunction in AECIIs can be blocked by Nrf2 inhibitor ML385. …”
    Get full text
    Article
  8. 1528

    Association of platelet to albumin ratio with metabolic dysfunction-associated steatotic liver disease based on the National Health and Nutrition Survey 2017–2018 by Jiao Xie, Qingliu He, David Fisher, Khrystyna Pronyuk, Erkin Musabaev, Lei Zhao

    Published 2025-03-01
    “…Abstract The prevalence and incidence of metabolic dysfunction-associated steatotic liver disease (MASLD) are significantly increasing globally, but the index of non-invasive disease is limited. …”
    Get full text
    Article
  9. 1529
  10. 1530
  11. 1531
  12. 1532

    An integrated population pharmacokinetic model of febuxostat in pediatric patients with hyperuricemia including gout and adult population of healthy subjects and patients with rena... by Ryutaro Iwama, Kimie Nishida, Daisuke Ishii, Takeshi Iijima

    Published 2024-12-01
    “…Integrated PopPK analysis of febuxostat used a nonlinear mixed‐effects modeling (NONMEM) program on plasma febuxostat concentration data for 2611 samples from Japanese pediatric patients with hyperuricemia including gout (n = 29) and from adult subjects who are healthy or have renal dysfunction (n = 113). …”
    Get full text
    Article
  13. 1533
  14. 1534

    Empowering Stroke Survivors: developing a patient version of guidelines to facilitate patient rehabilitation nursing of stroke patients with limb dysfunction in China by Dan Yang, Jingyuan Zhang, Meiqi Meng, Xuejing Li, Lijiao Yan, Jiaxin Fang, Ziyan Wang, Sihan Chen, Xiaoyan Zhang, Yufang Hao, Fang Wang

    Published 2025-01-01
    “…Further research is warranted to evaluate the implementation and effectiveness of this guideline within diverse Chinese healthcare context.…”
    Get full text
    Article
  15. 1535

    Prophylactic Use of Troxerutin Can Delay the Development of Diabetic Cognitive Dysfunction and Improve the Expression of Nrf2 in the Hippocampus on STZ Diabetic Rats by Songyun Zhang, Lingling Yuan, Lihui Zhang, Caige Li, Jie Li

    Published 2018-01-01
    “…This study was aimed at determining effect of troxerutin on the development of cognitive dysfunction and the expression level of Nrf2 in the hippocampus of streptozotocin (STZ) diabetic rats, when used in the early preventive stage. …”
    Get full text
    Article
  16. 1536

    Nanoscale therapeutics for erectile dysfunction: a meta-analysis of stem cell-derived extracellular vesicles as natural nanoparticles in diabetic rat models by Kecheng Lou, Junjie Hu, Jiayue Tong, Zhanshi Wang

    Published 2025-06-01
    “…Abstract Background Erectile dysfunction (ED), a prevalent male sexual disorder, severely impacts quality of life. …”
    Get full text
    Article
  17. 1537
  18. 1538
  19. 1539
  20. 1540

    Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C by Tom Ryu, Young Chang, Soung Won Jeong, Jeong-Ju Yoo, Sae Hwan Lee, Sang Gyune Kim, Young Seok Kim, Hong Soo Kim, Seung Up Kim, Jae Young Jang

    Published 2025-04-01
    “…Background/Aims Direct-acting antivirals (DAAs) effectively eradicate hepatitis C virus. This study investigated whether metabolic dysfunction influences the likelihood of fibrosis regression after DAA treatment in patients with chronic hepatitis C (CHC). …”
    Get full text
    Article